CORC

浏览/检索结果: 共10条,第1-10条 帮助

限定条件    
已选(0)清除 条数/页:   排序方式:
Efficacy of panitumumab (pmab) vs. cetuximab (cmab) in patients (pts) with wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) treated with prior bevacizumab (bev): Results from ASPECCT. 会议论文
作者:  Peeters, Marc;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano;  Ruff, Paul
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/05
Outcomes by hypomagnesemia (hypomag) in the randomized phase III ASPECCT trial of patients (pts) with chemofractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC). 会议论文
作者:  Peeters, Marc;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano;  Ruff, Paul
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/06
Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs. cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC). 会议论文
作者:  Price, Timothy Jay;  Newhall, Kathryn;  Peeters, Marc;  Kim, Tae Won;  Li, Jin
收藏  |  浏览/下载:2/0  |  提交时间:2019/12/13
Randomized phase 3 study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): outcomes by hypomagnesemia (hypomag) in ASPECCT 会议论文
作者:  Peeters, Marc;  Price, Timothy Jay;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/13
Randomized phase III study of panitumumab (pmab) vs. cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC): Outcomes by hypomagnesemia (hypomag) in ASPECCT. 会议论文
作者:  Price, Timothy Jay;  Peeters, Marc;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano
收藏  |  浏览/下载:5/0  |  提交时间:2019/12/13
Final results from ASPECCT: Randomized phase 3 non-inferiority study of panitumumab (pmab) vs cetuximab (cmab) in chemorefractory wild-type (WT) KRAS exon 2 metastatic colorectal cancer (mCRC) 会议论文
作者:  Price, Timothy Jay;  Peeters, Marc;  Kim, Tae Won;  Li, Jin;  Cascinu, Stefano
收藏  |  浏览/下载:7/0  |  提交时间:2019/12/13
Prevalence and outcomes of patients (pts) with EGFR S492R ectodomain mutations in ASPECCT: Panitumumab (pmab) vs cetuximab (cmab) in pts with chemorefractory wild-type KRAS exon 2 metastatic colorectal cancer (mCRC). 会议论文
作者:  Price, Timothy Jay;  Newhall, Kathryn;  Peeters, Marc;  Kim, Tae Won;  Li, Jin
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/19
MITOCHONDRIAL OXIDATIVE CAPACITY DURING ANAPHYLACTIC SHOCK IN SENSITIZED-RATS, A PRELIMINARY STUDY 会议论文
作者:  Oulehri, Walid;  Collange, Olivier;  Zheng, Feng;  Tacquard, Charles;  Charles, Anne-Laure
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/05
Mixed Flow Fans — Comparative Investigations of Blade Design Methods 会议论文
ASME, 2014
Anne Treder; Paul Uwe Thamsen; Steffen Hammer; Khaled Tunsi
收藏  |  浏览/下载:13/0  |  提交时间:2015/01/05
WCE 2010 - World Congress on Engineering 2010: Preface 会议论文
作者:  Korsunsky, Alexander M.;  Hunter, Andrew;  Hukins, David W.L.;  Gelman, Len;  Hogger, Christopher John
收藏  |  浏览/下载:3/0  |  提交时间:2019/12/10


©版权所有 ©2017 CSpace - Powered by CSpace